19 Dec, 2024 Our Predictions for Life Sciences in 2025 By DLA Piper Life Sciences As the New Year is fast approaching, we asked members of our Life Sciences team to share their predictions of what will be the key issues...
17 Dec, 2024 Spanish Pharmaceutical Industry Strategy 2024-2028: Strengthening Access, Innovation, and Sustainability By Elisa Lorenzo On 10 December 2024, the Spanish Government officially unveiled the Pharmaceutical Industry Strategy 2024-2028 ("the Strategy"), a...
16 Dec, 2024 NIS2 Series, Part 3 - What happens if you don’t comply? An overview of enforcement, supervisory measures, and liability for management bodies By Andreas Rüdiger Philipp Adelberg Introduction The NIS2 Directive (NIS2 or the Directive) introduces extensive new cybersecurity requirements for a wide range of...
10 Dec, 2024 Poland - Life Sciences Monthly Brief, November 2024 By DLA Piper Life Sciences Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
10 Dec, 2024 Life Sciences News in Italy: November 2024 By DLA Piper Life Sciences Regulatory MDCG updates Q&A on vigilance terms under MDR and IVDR On 11 November 2024, the Medical Device Coordination Group (MDCG)...
04 Dec, 2024 What should in-scope organisations do now to prepare for NIS2 compliance? By Cristina Criscuoli Federico Toscani Introduction In our second Network and Information Systems Directive (NIS2 Directive or Directive) article, we discuss the significant...
04 Dec, 2024 DLA Piper Genomics Series: Shaping the Future of Genomics - How Governments Worldwide Are Driving the Shift to Personalised Medicine By Kate Black As our Genomics mini-series has been exploring to date, genomic medicine is rapidly transforming healthcare across the globe, offering...